Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirey

Showing results (431-440 of 466) with videos related to

Pageof 47
Sort By:
Pediatric Research|August 28, 2019
Acute kidney injury risk-based screening in pediatric inpatients: a pragmatic randomized trialSara L Van Driest, Li Wang, Michael F McLemore, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing propertiesMohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing PropertiesMohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
Nano Letters|July 3, 2013
Low-loss, extreme subdiffraction photon confinement via silicon carbide localized surface phonon polariton resonatorsJoshua D Caldwell, Orest J Glembocki, Yan Francescato, et al.
Infection and Immunity|April 6, 2016
The Tick Protein Sialostatin L2 Binds to Annexin A2 and Inhibits NLRC4-Mediated Inflammasome ActivationXiaowei Wang, Dana K Shaw, Olivia S Sakhon, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 17, 2025
Treatment Modalities, Pain Response, and Referrals for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Retrospective StudyFrances C Wilson, Katelyn A Bruno, DeLisa Fairweather, et al.
Nature|May 3, 2013
The TLR4 antagonist Eritoran protects mice from lethal influenza infectionKari Ann Shirey, Wendy Lai, Alison J Scott, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Trials|July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Study protocol and statistical analysis plan for a randomized, double-blind, controlled trial evaluating recombinant human platelet-derived growth factor B (rhPDGF) in the reconstruction of complex head or neck defects following skin cancer excisionCyndi R Clark, Bryan S Blette, Ricardo A Torres Guzman, et al.
Pageof 47

Showing results (431-440 of 466) with videos related to

Sort By:
Pageof 47
Pediatric Research|August 28, 2019
Acute kidney injury risk-based screening in pediatric inpatients: a pragmatic randomized trialSara L Van Driest, Li Wang, Michael F McLemore, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing propertiesMohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing PropertiesMohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
Nano Letters|July 3, 2013
Low-loss, extreme subdiffraction photon confinement via silicon carbide localized surface phonon polariton resonatorsJoshua D Caldwell, Orest J Glembocki, Yan Francescato, et al.
Infection and Immunity|April 6, 2016
The Tick Protein Sialostatin L2 Binds to Annexin A2 and Inhibits NLRC4-Mediated Inflammasome ActivationXiaowei Wang, Dana K Shaw, Olivia S Sakhon, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 17, 2025
Treatment Modalities, Pain Response, and Referrals for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Retrospective StudyFrances C Wilson, Katelyn A Bruno, DeLisa Fairweather, et al.
Nature|May 3, 2013
The TLR4 antagonist Eritoran protects mice from lethal influenza infectionKari Ann Shirey, Wendy Lai, Alison J Scott, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Trials|July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Study protocol and statistical analysis plan for a randomized, double-blind, controlled trial evaluating recombinant human platelet-derived growth factor B (rhPDGF) in the reconstruction of complex head or neck defects following skin cancer excisionCyndi R Clark, Bryan S Blette, Ricardo A Torres Guzman, et al.
Pageof 47